Ashburton Global Equity Growth Fund

Quality, compounding stocks, generating sustainably growing excess cash returns

Select fund class

  • Global Equity Growth Fund: April 2024

    Dr James Cooke

    Economists often use all available time or word count to explain the past, then offer a balanced view of the future. Ideally, investors would focus more on their long-term forecasts, valuations, and views, largely ignoring the near term.

  • Global Equity Growth Fund: March 2024

    Dr James Cooke

    March was another positive month for global equities with the FTSE All-World Index gaining 3.1%. The energy and materials sectors were particularly positive with the equity market rally broadening out from Artificial Intelligence (AI) stocks.

  • Global Equity Growth Fund: February 2024

    Dr James Cooke

    February 2024 saw the global equity market continue its recent pattern with share price momentum and companies with higher growth rates providing better performance. Index returns continue to be driven by the narrow number of companies delivering great earnings growth.

  • Global Equity Growth Fund: December 2023

    Dr James Cooke

    Global equity returns continued to be positive in December with the FTSE All World index (USD) climbing +4.8%. Inflation fell faster than expected in several western economies.

  • Global Equity Growth Fund: November 2023

    Dr James Cooke

    November was a more positive month for equity markets with the FTSE All World Index gaining +9.2%. With inflation slowing faster than expected, European equity markets were among the best performing asset class, with the technology-driven US not too far behind.

  • Global Equity Growth Fund: October 2023

    Dr James Cooke

    Against a background of high inflation and continued strength in economic data in the US, central banks have continued to tighten market liquidity.

  • Global Equity Growth Fund: August 2023

    Dr James Cooke

    The best performers were Argonaut Gold (+25.1%), L’Occitane International (+15.7%) and Axon (+14.5%).

  • Global Equity Growth Fund: July 2023

    Dr James Cooke

    A number of smaller companies held performed well, led by Autolus Therapeutics +35.7%, Patterson +32.3% and L’Occitane International +27.5%.

  • Global Equity Growth Fund: June 2023

    Dr James Cooke

    The Global Equity Growth fund gained 4.7%. Align Technology’s share price recovered 25.1% to close to April highs...

  • Global Equity Growth Fund: May 2023

    Dr James Cooke

    Autolus Therapeutics was the best-performing stock held in the fund after full presentation of their successful clinical trial was received positively.